{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:06:15Z","timestamp":1794956775479,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH134519"],"award-info":[{"award-number":["R01MH134519"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS126185"],"award-info":[{"award-number":["R01NS126185"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67222-5","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T14:55:34Z","timestamp":1765378534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Editing DNA methylation in vivo"],"prefix":"10.1038","volume":"17","author":[{"given":"Richard","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0264-1488","authenticated-orcid":false,"given":"Xinyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0422-4680","authenticated-orcid":false,"given":"Luis F.","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel V. L.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre Antonio","family":"Adonnino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Lofts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3310-9331","authenticated-orcid":false,"given":"Jennifer","family":"Waldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Halmai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0044-4632","authenticated-orcid":false,"given":"Orrin","family":"Devinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0235-5038","authenticated-orcid":false,"given":"Kyle","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2799-2519","authenticated-orcid":false,"given":"X. Shawn","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"67222_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/science.add8643","volume":"379","author":"JY Wang","year":"2023","unstructured":"Wang, J. Y. & Doudna, J. A. CRISPR technology: a decade of genome editing is only the beginning. Science 379, eadd8643 (2023).","journal-title":"Science"},{"key":"67222_CR2","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.cell.2024.01.042","volume":"187","author":"M Pacesa","year":"2024","unstructured":"Pacesa, M., Pelea, O. & Jinek, M. Past, present, and future of CRISPR genome editing technologies. Cell 187, 1076\u20131100 (2024).","journal-title":"Cell"},{"key":"67222_CR3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","volume":"159","author":"LA Gilbert","year":"2014","unstructured":"Gilbert, L. A. et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159, 647\u2013661 (2014).","journal-title":"Cell"},{"key":"67222_CR4","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nature14136","volume":"517","author":"S Konermann","year":"2015","unstructured":"Konermann, S. et al. Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517, 583\u2013588 (2015).","journal-title":"Nature"},{"key":"67222_CR5","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/s41592-021-01207-2","volume":"18","author":"MP Gemberling","year":"2021","unstructured":"Gemberling, M. P. et al. Transgenic mice for in vivo epigenome editing with CRISPR-based systems. Nat. Methods 18, 965\u2013974 (2021).","journal-title":"Nat. Methods"},{"key":"67222_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-024-02320-1","author":"SR McCutcheon","year":"2024","unstructured":"McCutcheon, S. R., Rohm, D., Iglesias, N. & Gersbach, C. A. Epigenome editing technologies for discovery and medicine. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-024-02320-1 (2024).","journal-title":"Nat. Biotechnol."},{"key":"67222_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/ng1089","volume":"33","author":"R Jaenisch","year":"2003","unstructured":"Jaenisch, R. & Bird, A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33, 245\u2013254 (2003).","journal-title":"Nat. Genet."},{"key":"67222_CR8","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","volume":"20","author":"MVC Greenberg","year":"2019","unstructured":"Greenberg, M. V. C. & Bourc\u2019his, D. The diverse roles of DNA methylation in mammalian development and disease. Nat. Rev. Mol. Cell Biol. 20, 590\u2013607 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"67222_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrg.2017.33","volume":"18","author":"X Wu","year":"2017","unstructured":"Wu, X. & Zhang, Y. TET-mediated active DNA demethylation: mechanism, function and beyond. Nat. Rev. Genet. 18, 517\u2013534 (2017).","journal-title":"Nat. Rev. Genet."},{"key":"67222_CR10","doi-asserted-by":"publisher","first-page":"50380","DOI":"10.18632\/oncotarget.10394","volume":"7","author":"SR Choudhury","year":"2016","unstructured":"Choudhury, S. R. et al. Optogenetic regulation of site-specific subtelomeric DNA methylation. Oncotarget 7, 50380\u201350391 (2016).","journal-title":"Oncotarget"},{"key":"67222_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cell.2016.08.056","volume":"167","author":"XS Liu","year":"2016","unstructured":"Liu, X. S. et al. Editing DNA methylation in the mammalian genome. Cell 167, 233\u2013247.e217 (2016).","journal-title":"Cell"},{"key":"67222_CR12","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.1093\/nar\/gkw159","volume":"44","author":"A Vojta","year":"2016","unstructured":"Vojta, A. et al. Repurposing the CRISPR-Cas9 system for targeted DNA methylation. Nucleic Acids Res. 44, 5615\u20135628 (2016).","journal-title":"Nucleic Acids Res."},{"key":"67222_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/celldisc.2016.9","volume":"2","author":"X Xu","year":"2016","unstructured":"Xu, X. et al. A CRISPR-based approach for targeted DNA demethylation. Cell Discov. 2, 16009 (2016).","journal-title":"Cell Discov."},{"key":"67222_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cell.2016.09.006","volume":"167","author":"A Amabile","year":"2016","unstructured":"Amabile, A. et al. Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing. Cell 167, 219\u2013232 e214 (2016).","journal-title":"Cell"},{"key":"67222_CR15","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2018.01.012","volume":"172","author":"XS Liu","year":"2018","unstructured":"Liu, X. S. et al. Rescue of fragile X syndrome neurons by DNA methylation editing of the FMR1 gene. Cell 172, 979\u2013992.e976 (2018).","journal-title":"Cell"},{"key":"67222_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.add4666","volume":"15","author":"J Qian","year":"2023","unstructured":"Qian, J. et al. Multiplex epigenome editing of MECP2 to rescue Rett syndrome neurons. Sci. Transl. Med. 15, eadd4666 (2023).","journal-title":"Sci. Transl. Med."},{"key":"67222_CR17","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1093\/nar\/gkz1214","volume":"48","author":"J Halmai","year":"2020","unstructured":"Halmai, J. et al. Artificial escape from XCI by DNA methylation editing of the CDKL5 gene. Nucleic Acids Res. 48, 2372\u20132387 (2020).","journal-title":"Nucleic Acids Res."},{"key":"67222_CR18","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.tins.2019.10.003","volume":"42","author":"XS Liu","year":"2019","unstructured":"Liu, X. S. & Jaenisch, R. Editing the epigenome to tackle brain disorders. Trends Neurosci. 42, 861\u2013870 (2019).","journal-title":"Trends Neurosci."},{"key":"67222_CR19","doi-asserted-by":"publisher","first-page":"5860","DOI":"10.1073\/pnas.93.12.5860","volume":"93","author":"M Lakso","year":"1996","unstructured":"Lakso, M. et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA 93, 5860\u20135865 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67222_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41569-018-0107-8","volume":"16","author":"MS Sabatine","year":"2019","unstructured":"Sabatine, M. S. PCSK9 inhibitors: clinical evidence and implementation. Nat. Rev. Cardiol. 16, 155\u2013165 (2019).","journal-title":"Nat. Rev. Cardiol."},{"key":"67222_CR21","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","volume":"23","author":"RE Amir","year":"1999","unstructured":"Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185\u2013188 (1999).","journal-title":"Nat. Genet."},{"key":"67222_CR22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(20)30217-9","volume":"19","author":"AJ Sandweiss","year":"2020","unstructured":"Sandweiss, A. J., Brandt, V. L. & Zoghbi, H. Y. Advances in understanding of Rett syndrome and MECP2 duplication syndrome: prospects for future therapies. Lancet Neurol. 19, 689\u2013698 (2020).","journal-title":"Lancet Neurol."},{"key":"67222_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2022.01.007","author":"NB Grimm","year":"2022","unstructured":"Grimm, N. B. & Lee, J. T. Selective Xi reactivation and alternative methods to restore MECP2 function in Rett syndrome. Trends Genet. https:\/\/doi.org\/10.1016\/j.tig.2022.01.007 (2022).","journal-title":"Trends Genet."},{"key":"67222_CR24","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1073\/pnas.1621356114","volume":"114","author":"S Sripathy","year":"2017","unstructured":"Sripathy, S. et al. Screen for reactivation of MeCP2 on the inactive X chromosome identifies the BMP\/TGF-beta superfamily as a regulator of XIST expression. Proc. Natl. Acad. Sci. USA 114, 1619\u20131624 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67222_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/85899","volume":"27","author":"J Guy","year":"2001","unstructured":"Guy, J., Hendrich, B., Holmes, M., Martin, J. E. & Bird, A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet 27, 322\u2013326 (2001).","journal-title":"Nat. Genet"},{"key":"67222_CR26","doi-asserted-by":"publisher","first-page":"R414","DOI":"10.1016\/j.cub.2011.04.022","volume":"21","author":"DA Starr","year":"2011","unstructured":"Starr, D. A. KASH and SUN proteins. Curr. Biol. 21, R414\u2013R415 (2011).","journal-title":"Curr. Biol."},{"key":"67222_CR27","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1002\/stem.1180","volume":"30","author":"M Yazdani","year":"2012","unstructured":"Yazdani, M. et al. Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons. Stem Cells 30, 2128\u20132139 (2012).","journal-title":"Stem Cells"},{"key":"67222_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.nbd.2013.04.020","volume":"58","author":"IT Wang","year":"2013","unstructured":"Wang, I. T., Reyes, A. R. & Zhou, Z. Neuronal morphology in MeCP2 mouse models is intrinsically variable and depends on age, cell type, and Mecp2 mutation. Neurobiol. Dis. 58, 3\u201312 (2013).","journal-title":"Neurobiol. Dis."},{"key":"67222_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.stem.2013.09.001","volume":"13","author":"Y Li","year":"2013","unstructured":"Li, Y. et al. Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell 13, 446\u2013458 (2013).","journal-title":"Cell Stem Cell"},{"key":"67222_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2021.109081","volume":"352","author":"LF Farrow","year":"2021","unstructured":"Farrow, L. F., Andronicos, N. M., McDonald, P. G. & Hamlin, A. S. Quantitative determination of neuronal size and density using flow cytometry. J. Neurosci. Methods 352, 109081 (2021).","journal-title":"J. Neurosci. Methods"},{"key":"67222_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2022.03.010","author":"AL Mattei","year":"2022","unstructured":"Mattei, A. L., Bailly, N. & Meissner, A. DNA methylation: a historical perspective. Trends Genet. https:\/\/doi.org\/10.1016\/j.tig.2022.03.010 (2022).","journal-title":"Trends Genet."},{"key":"67222_CR32","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41586-024-07087-8","volume":"627","author":"MA Cappelluti","year":"2024","unstructured":"Cappelluti, M. A. et al. Durable and efficient gene silencing in vivo by hit-and-run epigenome editing. Nature 627, 416\u2013423 (2024).","journal-title":"Nature"},{"key":"67222_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/science.ado7082","volume":"384","author":"EN Neumann","year":"2024","unstructured":"Neumann, E. N. et al. Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor. Science 384, ado7082 (2024).","journal-title":"Science"},{"key":"67222_CR34","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/nbt.4005","volume":"35","author":"H Yin","year":"2017","unstructured":"Yin, H. et al. Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing. Nat. Biotechnol. 35, 1179\u20131187 (2017).","journal-title":"Nat. Biotechnol."},{"key":"67222_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","volume":"593","author":"K Musunuru","year":"2021","unstructured":"Musunuru, K. et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature 593, 429\u2013434 (2021).","journal-title":"Nature"},{"key":"67222_CR36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/mt.2009.246","volume":"18","author":"L Wang","year":"2010","unstructured":"Wang, L. et al. Systematic evaluation of AAV vectors for liver directed gene transfer in murine models. Mol. Ther. 18, 118\u2013125 (2010).","journal-title":"Mol. Ther."},{"key":"67222_CR37","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.1138389","volume":"315","author":"J Guy","year":"2007","unstructured":"Guy, J., Gan, J., Selfridge, J., Cobb, S. & Bird, A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143\u20131147 (2007).","journal-title":"Science"},{"key":"67222_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.biopsych.2022.08.020","volume":"93","author":"MA Krzisch","year":"2023","unstructured":"Krzisch, M. A. et al. Fragile X syndrome patient-derived neurons developing in the mouse brain show FMR1-dependent phenotypes. Biol. Psychiatry 93, 71\u201381 (2023).","journal-title":"Biol. Psychiatry"},{"key":"67222_CR39","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41586-019-1668-3","volume":"575","author":"WA Flavahan","year":"2019","unstructured":"Flavahan, W. A. et al. Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs. Nature 575, 229\u2013233 (2019).","journal-title":"Nature"},{"key":"67222_CR40","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1101\/lm.042739.116","volume":"23","author":"AM Oliveira","year":"2016","unstructured":"Oliveira, A. M. DNA methylation: a permissive mark in memory formation and maintenance. Learn. Mem. 23, 587\u2013593 (2016).","journal-title":"Learn. Mem."},{"key":"67222_CR41","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","volume":"159","author":"RJ Platt","year":"2014","unstructured":"Platt, R. J. et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159, 440\u2013455 (2014).","journal-title":"Cell"},{"key":"67222_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"67222_CR43","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nbt.2889","volume":"32","author":"X Wu","year":"2014","unstructured":"Wu, X. et al. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat. Biotechnol. 32, 670\u2013676 (2014).","journal-title":"Nat. Biotechnol."},{"key":"67222_CR44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"67222_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"67222_CR46","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu, G., Wang, L. G. & He, Q. Y. ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382\u20132383 (2015).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67222-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67222-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67222-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:02:28Z","timestamp":1768406548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67222-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67222"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67222-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"O.D. has equity in Epitor Therapeutics, Regel Therapeutics, Ajna Biosciences, Blackrock Neurotech, ConnectRN, Tevard Therapeutics, and PhiFund Ventures. K.F. is a SAB member for Epitor Therapeutics. X.S.L. is a co-founder of Epitor Therapeutics. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"527"}}